InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,554.13
(
1.07%
)
US TECH 100
18,724.40
(
2.06%
)
Dow Jones
40,861.71
(
0.31%
)
Brent Oil
70.80
(
0.39%
)
Bitcoin
58,232.24
(
1.55%
)

Replies to post #57 on Regeneron Pharmaceuticals Inc (REGN)

Replies to #57 on Regeneron Pharmaceuticals Inc (REGN)
icon url

DewDiligence

02/10/14 5:39 PM

#58 RE: starbuxsux #57

The Eylea data released today are from the 2-year follow-up; the primary endpoint of the Eylea DME trials was visual acuity at one year.